PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.00 - 0.01
0.00 - 0.02
289 / 496.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
22.39%
Revenue growth at 75-90% of ECL.AX's 28.40%. Bill Ackman would push for innovation or market expansion to catch up.
9.26%
Gross profit growth under 50% of ECL.AX's 30.51%. Michael Burry would be concerned about a severe competitive disadvantage.
-4.78%
Negative EBIT growth while ECL.AX is at 82.04%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-4.78%
Negative operating income growth while ECL.AX is at 82.04%. Joel Greenblatt would press for urgent turnaround measures.
-45.78%
Negative net income growth while ECL.AX stands at 27.14%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-50.00%
Negative EPS growth while ECL.AX is at 29.54%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-50.00%
Negative diluted EPS growth while ECL.AX is at 29.54%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-6.74%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-6.33%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
-124.17%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
37.44%
Positive FCF growth while ECL.AX is negative. John Neff would see a strong competitive edge in net cash generation.
-67.18%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
1.70%
Positive 5Y CAGR while ECL.AX is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
23.51%
3Y revenue/share CAGR under 50% of ECL.AX's 60.11%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
88.10%
Positive long-term OCF/share growth while ECL.AX is negative. John Neff would see a structural advantage in sustained cash generation.
-117.41%
Negative 5Y OCF/share CAGR while ECL.AX is at 48.44%. Joel Greenblatt would question the firm’s operational model or cost structure.
-124.87%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
106.06%
Net income/share CAGR at 75-90% of ECL.AX's 121.44%. Bill Ackman would press for strategic moves to boost long-term earnings.
133.33%
5Y net income/share CAGR above 1.5x ECL.AX's 5.22%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
100.00%
3Y net income/share CAGR above 1.5x ECL.AX's 49.91%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
9648.54%
Positive 5Y equity/share CAGR while ECL.AX is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
260.24%
3Y equity/share CAGR above 1.5x ECL.AX's 6.82%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
4.39%
AR growth is negative/stable vs. ECL.AX's 24.89%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
-11.17%
Inventory is declining while ECL.AX stands at 41.27%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
0.02%
Asset growth well under 50% of ECL.AX's 2.64%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
13.30%
Positive BV/share change while ECL.AX is negative. John Neff sees a clear edge over a competitor losing equity.
2.27%
Debt growth of 2.27% while ECL.AX is zero. Bruce Berkowitz sees additional leverage that must yield profitable expansions to be worthwhile.
-100.00%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
17.47%
SG&A growth well above ECL.AX's 9.98%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.